GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GelStat Corp (OTCPK:GSAC) » Definitions » Net Margin %

GelStat (GelStat) Net Margin % : -2,000.00% (As of Dec. 2008)


View and export this data going back to 1996. Start your Free Trial

What is GelStat Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. GelStat's Net Income for the three months ended in Dec. 2008 was $-0.10 Mil. GelStat's Revenue for the three months ended in Dec. 2008 was $0.01 Mil. Therefore, GelStat's net margin for the quarter that ended in Dec. 2008 was -2,000.00%.

The historical rank and industry rank for GelStat's Net Margin % or its related term are showing as below:


GSAC's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.76
* Ranked among companies with meaningful Net Margin % only.

GelStat Net Margin % Historical Data

The historical data trend for GelStat's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GelStat Net Margin % Chart

GelStat Annual Data
Trend Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,540.00 -1,713.61 -776.92 -6,016.67 -2,013.04

GelStat Quarterly Data
Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13,100.00 -1,290.91 -2,800.00 -4,050.00 -2,000.00

Competitive Comparison of GelStat's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, GelStat's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GelStat's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GelStat's Net Margin % distribution charts can be found below:

* The bar in red indicates where GelStat's Net Margin % falls into.



GelStat Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

GelStat's Net Margin for the fiscal year that ended in Dec. 2008 is calculated as

Net Margin=Net Income (A: Dec. 2008 )/Revenue (A: Dec. 2008 )
=-0.463/0.023
=-2,013.04 %

GelStat's Net Margin for the quarter that ended in Dec. 2008 is calculated as

Net Margin=Net Income (Q: Dec. 2008 )/Revenue (Q: Dec. 2008 )
=-0.1/0.005
=-2,000.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GelStat  (OTCPK:GSAC) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


GelStat Net Margin % Related Terms

Thank you for viewing the detailed overview of GelStat's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


GelStat (GelStat) Business Description

Traded in Other Exchanges
N/A
Address
333 SE 2nd Avenue, Suite 2000, Miami, FL, USA, 33131
GelStat Corp is a consumer healthcare company operating in the US. It is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The company's lead product is Gelstat Migraine, which is a patented OTC homeopathic drug for use as a first-line, acute treatment for migraine and migraine-like headaches. The Gelstat Migraine is developed to provide acute relief from headache pain as well as other symptoms associated with a migraine. The other products of the company include CHEWS 2 LOSE, which is a diet aide in the form of an all-natural appetite suppressant gum; All Natural Speed which targets specific quick-fix energy user groups; and GelStat Sleep, which provides relief from sleep disorders and their associated symptoms.
Executives
Adrian Graham Goldfarb director 7660 CENTURION PARKWAY, SUITE 100, JACKSONVILLE FL 32256
Donald Miller director, officer: Chief Financial Officer
Garry N Lowenthal officer: Chief Financial Officer 2551 38TH AVENUE NE, STE 135, MINNEAPOLIS MN 55421

GelStat (GelStat) Headlines

No Headlines